2 research outputs found
A longitudinal follow-up of autoimmune polyendocrine syndrome type 1
Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971337/Context:
Autoimmune polyendocrine syndrome type 1 (APS1) is a childhood-onset monogenic disease defined
by the presence of two of the three major components: hypoparathyroidism, primary adrenocortical insuffi-
ciency, and chronic mucocutaneous candidiasis (CMC). Information on longitudinal follow-up of APS1 is sparse.
Objective:
To describe the phenotypes of APS1 and correlate the clinical features with autoantibody profiles and
autoimmune regulator (
AIRE)
mutations during extended follow-up (1996–2016).
Patients:
All known Norwegian patients with APS1.
Results:
Fifty-two patients from 34 families were identified. The majority presented with one of the major disease
components during childhood. Enamel hypoplasia, hypoparathyroidism, and CMC were the most frequent compo-
nents.Withage,mostpatientspresentedthreetofivediseasemanifestations,althoughsomehadmilderphenotypes
diagnosed in adulthood. Fifteen of the patients died during follow-up (median age at death, 34 years) or were
deceasedsiblingswithahighprobabilityofundisclosedAPS1.Allexceptthreehadinterferon-
)autoantibodies,and
allhadorgan-specificautoantibodies.Themostcommon
AIRE
mutationwasc.967_979del13,foundinhomozygosity
in 15 patients. A mild phenotype was associated with the splice mutation c.879
1G
A. Primary adrenocortical
insufficiency and type 1 diabetes were associated with protective human leucocyte antigen genotypes.
Conclusions:
Multiple presumable autoimmune manifestations, in particular hypoparathyroidism, CMC, and
enamel hypoplasia, should prompt further diagnostic workup using autoantibody analyses (eg, interferon-
)
and
AIRE
sequencing to reveal APS1, even in adults. Treatment is complicated, and mortality is high. Structured
follow-up should be performed in a specialized center
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Chronic mucocutaneous candidiasis (CMC) is frequently associated with T cell immunodeficiencies. Specifically, the proinflammatory IL-17A–producing Th17 subset is implicated in protection against fungi at epithelial surfaces. In autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED, or autoimmune polyendocrine syndrome 1), CMC is often the first sign, but the underlying immunodeficiency is a long-standing puzzle. In contrast, the subsequent endocrine features are clearly autoimmune, resulting from defects in thymic self-tolerance induction caused by mutations in the autoimmune regulator (AIRE). We report severely reduced IL-17F and IL-22 responses to both Candida albicans antigens and polyclonal stimulation in APECED patients with CMC. Surprisingly, these reductions are strongly associated with neutralizing autoantibodies to IL-17F and IL-22, whereas responses were normal and autoantibodies infrequent in APECED patients without CMC. Our multicenter survey revealed neutralizing autoantibodies against IL-17A (41%), IL-17F (75%), and/ or IL-22 (91%) in >150 APECED patients, especially those with CMC. We independently found autoantibodies against these Th17-produced cytokines in rare thymoma patients with CMC. The autoantibodies preceded the CMC in all informative cases. We conclude that IL-22 and IL-17F are key natural defenders against CMC and that the immunodeficiency underlying CMC in both patient groups has an autoimmune basis